Results 61 to 70 of about 15,877,700 (238)

Prescribing placebos ethically: the appeal of negatively informed consent [PDF]

, 2009
Kihlbom has recently argued that a system of seeking negatively informed consent might be preferable in some cases to the ubiquitous informed consent model. Although this theory is perhaps not powerful enough to supplant informed consent in most settings,
Shaw, D.M.
core   +1 more source

Are Sham Acupuncture Interventions More Effective than (Other) Placebos? A Re-Analysis of Data from the Cochrane Review on Placebo Effects [PDF]

, 2010
Background and Objective: A recent Cochrane review on placebo interventions for all kinds of conditions found that `physical placebos' (which included sham acupuncture) were associated with larger effects over no-treatment control groups than ...
Linde, Klaus, Karin Niemann, Meissner, Karin, Karin Meissner, Klaus Linde, Niemann, Karin, Linde, Klaus;Niemann, Karin;Meissner, Karin, Linde, K;Niemann, K;Meissner, K   +7 more
core   +1 more source

Placebos in primary care? a nominal group study explicating UK GP and patient views of six theoretically plausible models of placebo practice

BMJ Open, 2020
ObjectivesTo better understand which theoretically plausible placebogenic techniques might be acceptable in UK primary care.DesignA qualitative study using nominal group technique and thematic analysis.
Adam W A Geraghty, Mohana Ratnapalan, Beverly Coghlan, Mengxin Tan, Hazel Everitt, George Lewith, Felicity L Bishop   +6 more
doaj   +1 more source

Effects of an open-label placebo intervention on reactions to social exclusion in healthy adults: a randomized controlled trial

Scientific Reports, 2023
Social exclusion, that is being left out by others, can have adverse consequences for individuals’ psychological well-being. Even short-term experiences of social exclusion strongly threaten basic psychological needs and cause so-called social pain ...
Leonie Stumpp, Melissa Jauch, Dilan Sezer, Jens Gaab, Rainer Greifeneder   +4 more
doaj   +1 more source

Informed consent and placebo effects: a content analysis of information leaflets to identify what clinical trial participants are told about placebos [PDF]

, 2012
BackgroundPlacebo groups are used in randomised clinical trials (RCTs) to control for placebo effects, which can be large. Participants in trials can misunderstand written information particularly regarding technical aspects of trial design such as ...
Alison E. M. Adams (317941), George T. Lewith (317942), Kaptchuk, Ted J., Ted J Kaptchuk, Ted J. Kaptchuk (234474), Bishop Felicity L., Lewith George T., Adams, Alison E. M., Kaptchuk, Ted, Bishop, Felicity L., Felicity L. Bishop (317940), Adams Alison E. M., Alison E M Adams, Kaptchuk Ted J., Lewith, George, Lewith, George T., Felicity L Bishop, Adams, Alison E.M., George T Lewith   +18 more
core   +1 more source

Effects of open label placebos and reappraisal on disgust activation

, 2023
Die vorliegende Arbeit vergleicht die Anwendung der Emotionsregulationsstrategie des Cog- nitive Reappraisals mit der Einnahme eines Open-label Placebos und der Kontrollbedingung (Passive Viewing) auf die Ekelverarbeitung.
Geyer, Leonie Charlotte
core   +2 more sources

Open-label placebo treatment of women with premenstrual syndrome: study protocol of a randomised controlled trial

BMJ Open, 2020
IntroductionRecent evidence suggests that for certain clinical conditions, placebos can improve clinical outcomes even without deception. These so-called open-label placebos (OLPs) bear the advantage of a significant lower risk of adverse events and ...
Cosima Locher, Irving Kirsch, Antje Frey Nascimento, Jens Gaab, Joe Kossowsky, Andrea Meyer   +5 more
doaj   +1 more source

The Role of Rituals in Open-Label Placebo Effects

, 2023
Placebos have been shown to generate beneficial effects on mental health and well-being even when they are administered openly, without deception. However, research on open-label placebos (OLPs) is limited and there is still some uncertainty regarding how OLP effects can be created consistently.
openaire   +2 more sources

(Open Label) Placebos, Sleep & Food

, 2023
Open-label placebos (OLPs) are administered without the deception of participants or patients. Placebo recipients are informed that they are receiving a physiologically inert substance or another type of sham treatment.
Jonas Potthoff
core   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source